A uniform activated B-cell–like immunophenotype might explain the poor prognosis of primary central nervous system lymphomas: analysis of 83 cases

S Camilleri-Broët, E Criniere, P Broët, V Delwail… - Blood, 2006 - ashpublications.org
Most primary central nervous system lymphomas (PCNSLs) in immunocompetent patients
are diffuse large B-cell lymphomas (DLBCLs), characterized by poor prognosis, compared …

[HTML][HTML] Single-cell spatial landscapes of the lung tumour immune microenvironment

…, VSK Manem, R Rayes, PM Siegel, S Camilleri-Broët… - Nature, 2023 - nature.com
Single-cell technologies have revealed the complexity of the tumour immune microenvironment
with unparalleled resolution 1 , 2 , 3 , 4 , 5 , 6 , 7 , 8 – 9 . Most clinical strategies rely on …

[HTML][HTML] HER2 Status in Ovarian Carcinomas: A Multicenter GINECO Study of 320 Patients

…, B Weber, E Pujade-Lauraine, S Camilleri-Broët - PloS one, 2007 - journals.plos.org
Background Despite a typically good response to first-line combination chemotherapy, the
prognosis for patients with advanced ovarian cancer remains poor because of acquired …

Neurotensin receptor 1 determines the outcome of non–small cell lung cancer

M Alifano, F Souazé, S Dupouy, S Camilleri-Broët… - Clinical Cancer …, 2010 - AACR
Purpose: This study aimed to investigate the role of the neurotensin/neurotensin receptor I (NTSR1)
complex in non–small cell lung cancer (NSCLC) progression. Experimental Design: …

Catamenial and noncatamenial, endometriosis-related or nonendometriosis-related pneumothorax referred for surgery

…, P Falcoz, A Gompel, S Camilleri-Broet… - American journal of …, 2007 - atsjournals.org
Rationale: Catamenial and endometriosis-related pneumothorax are considered relatively
rare entities. Their clinical characteristics and outcome are incompletely known. Objectives: …

Primary central nervous system lymphomas in 72 immunocompetent patients: pathologic findings and clinical correlations

S Camilleri-Broet, A Martin, A Moreau… - American journal of …, 1998 - academic.oup.com
We reviewed 72 primary central nervous system lymphomas occurring in immunocompetent
patients. The cases were reviewed for clinical data, histology, immunophenotype, bcl-2 and …

[HTML][HTML] SMARCA4 loss is synthetic lethal with CDK4/6 inhibition in non-small cell lung cancer

…, AR Judkins, S Jung, S Camilleri-Broet… - Nature …, 2019 - nature.com
Tumor suppressor SMARCA4 (BRG1), a key SWI/SNF chromatin remodeling gene, is
frequently inactivated in cancers and is not directly druggable. We recently uncovered that …

Catamenial pneumothorax and endometriosis-related pneumothorax: clinical features and risk factors

…, M Alifano, G Plu-Bureau, S Camilleri-Broet… - Human …, 2011 - academic.oup.com
BACKGROUND Catamenial pneumothorax and thoracic endometriosis (TE) are still under
diagnosed. The purpose of this study is to increase the diagnostic accuracy for these …

A Comparative and Integrative Approach Identifies ATPase Family, AAA Domain Containing 2 as a Likely Driver of Cell Proliferation in Lung Adenocarcinoma

R Fouret, J Laffaire, P Hofman, M Beau-Faller… - Clinical cancer …, 2012 - AACR
Purpose: To identify genetic changes that could drive cancer pathogenesis in never and ever
smokers with lung adenocarcinoma. Experimental Design: We analyzed the copy number …

CD44 promotes PD-L1 expression and its tumor-intrinsic function in breast and lung cancers

…, Q Li, S Jung, AV Gonzalez, S Camilleri-Broet… - Cancer research, 2020 - AACR
Sophie Camilleri-Broet; Sophie Camilleri-Broet … Gonzalez, Sophie Camilleri-Broet,
Marie-Christine Guiot, Morag Park, Josie Ursini-Siegel, Sidong Huang; CD44 Promotes PD-L1 …